"Curriculum Vitae" Hamid Ahmadieh MD. Degree: Work Address: Work Phone: Email: Fields Of Activity: Professor Ophthalmic Research Center, Labbafinejad Medical Center, Pasdaran Ave. Boostan 9 St. Tehran, 16666, Iran +98-21-22585952 ; +98-21-23601 ahmadieh@sbmu.ac.ir; hahmadieh@hotmail.com Retina Certifications 1978 1982 1986 General Medicine Iranian Board of Ophthalmology Fellowship of Medical and Surgical Retina Academic position 1986-1993 Assistant Professor of Ophthalmology-Shahid Beheshti University of Medical Sciences 1993- 1998 Associate Professor of Ophthalmology-Shahid Beheshti University of Medical Sciences 1999- Present Professor of Ophthalmology-Shahid Beheshti University of Medical Sciences Executive appointments 1986-2012 Director, Vitreoretinal Service-Labbafinejad Medical Center 1987-2008 Iranian Board of Ophthalmology, Member 1988-1996 Iranian Society of Ophthalmology, Member of the Executive Committee 1989-1996 Director, Residency Training (Ophthalmology)-Labbafinejad Medical Center & Shahid Beheshti University of Medical Sciences 2006-Present Editor-in-Chief, Journal of Ophthalmic & Vision Research 2007-Present Head of Iranian Vitreoretina Society (IrVRS) 2008-Present Research Deputy of the Ophthalmic Research Center 2011- Present Vice-President of Iranian Society of Ophthalmology Membership 1982-Present Iranian Society of Ophthalmology 1986-Present American Academy of Ophthalmology 1994-Present Iranian Vitreoretina Society (The Founder) 2001- Present American Society of Retina Specialists (ASRS) 2006- Present International Society of Ocular Trauma (ISOT) 2007-Present The Association for Research in Vision and Ophthalmology (ARVO) 2007-2009 European Association for Vision and Eye Research (EVER) 2010-Present European Society of Retina Specialists (EURETINA) Interest Medical and Surgical Retina Retinal Cell Biology Awards and Honors Distinguished Ophthalmologist, Iranian Society of Ophthalmology, 2003 Distinguished Researcher, Shahid Beheshti University of Medical Sciences, 2003 Recipient of 9th Razi Research Festival Award, 2003 Achievement Award, American Academy of Ophthalmology, 2006 Outstanding Researcher with High Citation, 12 the Razi Research Festival on Medical Sciences, 2006 Distinguished Researcher, Shahid Beheshti University of Medical Sciences, 2009 Honor Award, American Society of Retina Specialists, 2010 Distinguished Researcher, Shahid Beheshti University of Medical Sciences, 2014 Peyman Award, Chams Festival 2015 Editorial Work Editor - in – Chief, Journal of Ophthalmic & Vision Research Member of the Editorial Board, International Scholarly Research Notices (Ophthalmology) Published Books Pediatric Cataract Surgery. Wilson E., Trivedi R.H., Pandey S.K., Lippincott Williams & Wilkins, USA, Chapters: 20,43. Reviewer 1. 2. 3. 4. 5. 6. Ophthalmology (The journal of American Academy of Ophthalmology) American Journal of Ophthalmology Retina Acta Ophthalmologica Middle East African Journal of Ophthalmology Indian Journal of Ophthalmology 7. BMC Ophthalmology 8. ISRN Ophthalmology 9. Saudi Journal of Ophthalmology 10. Archives of Iranian Medicine 11. Iranian Journal of Ophthalmology 12. Bina Journal of Ophthalmology International papers 1) Ahmadieh H, Sajjadi H, Azarmina M, Faghihi H. Vitrectomy in chronic uveitis. Medical Journal of Iran 1989; 3: 113-117. 2) Ahmadieh H, Sajjadi H, Azarmina M, Kalani H. Association of herpetic encephalitis with acute retinal necrosis syndrome. Annals of Ophthalmology 1991; 23: 215-219. 3) Ahmadieh H, Soheilian M, Sajjadi H, Azarmina M, Abrishami M. Vitrectomy in ocular trauma-Factors influencing final visual outcome. Retina 1993; 13: 107-113 4) Ahmadieh H, Roodpeyma S, Azarmina M, Soheilian M, Sajjadi H. Bilateral simultaneous optic neuritis in childhood systemic lupus erythematosus. Journal of Neuro-Ophthalmology 1994; 14: 84-86. 5) Soheilian M, Ahmadieh H, Sajjadi H, Azarmina M, Miratashi AM, Peyman GA. Temporary keratoprosthesis for surgical management of complicated combined anterior and posterior segment injuries to the eye: combat versus noncombat- injury cases. Ophthalmic Surgery 1994; 25:452-457. 6) Sajjadi H, Soheilian M, Ahmadieh H, Hassanein K, Parvin M, Azarmina M, Ehyaee V, Amiransari B. Low-dose cyclosporin-A therapy in Behcet’s disease. Journal of Ocular Pharmacology 1994; 10: 553-557. 7) Ahmadieh H, Sajjadi H, Azarmina M, Soheilian M, Baharivand N. Surgical management of intraretinal foreign bodies. Retina1994; 14: 397-403. 8) Soheilian M, Ahmadieh H, Afghan MH, Sajjadi H, Azarmina M, Peyman GA. Posterior segment triple surgery after traumatic eye injuries. Ophthalmic Surgery 1995; 26: 338-342. 9) Soheilian M, Karimian F, Javadi MA, Sajjadi H, Ahmadieh H, Azarmina M, Valaee N, Rahmani B, Peyman GA. Surgical management of cataract and posterior chamber intraocular lens implantation in Fuchs' heterochromic iridocyclitis. International Ophthalmology 1997; 21: 137-141. 10) Ahmadieh H, Javadi MA, Ahmady M, Karimian F, Einollahi B, Zare M, Dehghan MH, Mashyekhi A, Valaei N, Soheilian M, Sajjadi H. Primary Capsulectomy and Anterior Vitrectomy Combined with Lensectomy and PC IOL Implantation in Children: Limbal vs. Pars Plana Approach. Journal of Cataract and Refractive Surgery 1999; 25: 768- 775. 11) Ahmadieh H, Entezari M, Sajjadi H, Soheilian M, Azarmina M, Dehghan MH, Mashayekhi A. The factors influencing anatomic and visual results in primary scleral buckling. European Journal of Ophthalmology 2000; 10: 153-159. 12) Ahmadieh H, Javadi MA. Intra-ocular lens implantation in children. Current Opinion in Ophthalmology 2001; 12: 30- 34. 13) Ahmadieh H. Ocular injuries caused by intraocular or retrobulbar foreign bodies. Ophthalmology 2001; 108: 1170 (Letter to the editor) 14) Soheilian M, Vistamehr S, Rahmani B, Ahmadieh H, Azarmina M, Mashayekhi A, Sajjadi H, Dehghan MH. “Outcome of surgical (pars plicata and limbal lensectomy, vitrectomy) and non-surgical management of persistent fetal vasculature (PFV): an analysis of 54 eyes.” Eur J Ophthalmol 2002; 12: 523-533. 15) Bagheri A, Ahmadieh H, Repka MX. “Acquired cyclic strabismus in an adult.” J Pediatr Ophthalmol Strabismus 2002; 39: 310-312. 16) Soheilian M, Vistamehr S, Rahmani B, Ahmadieh H, Azarmina M, Mashayekhi A, Sajjadi H, Dehghan MH. “Outcomes of surgical and nonsurgical management of persistent fetal vadculature”, Annals of Ophthalmology 2003; 35: 28-37. 17) Banaee T, Ahmadieh H, Ciardella AP. “Crystalline retinopathy associated with retinal dialysis and chronic retinal detachment.” Retina 2003; 23: 887. 18) Ghanbari H, Ahmadieh H. “Aggravation of proliferative diabetic retinopathy after laser in situ keratomileusis” J Cataract Refract Surg 2003; 26: 2232-2233. 19) Ahmadieh H, Soheilian M, Azarmina M, Dehghan MH, Mashayekhi A. “Surgical management of retinal detachment secondary to acute retinal necrosis: clinical features, surgical techniques, and long-term results.” Jpn J Ophthalmol 2003; 47: 484-491. 20) Soheilian M, Abolhasani A, Ahmadieh H, Azarmina M, Dehgan MH, Mashayekhi A, Siadar F, Moshfeghi AA, Peyman GA. Management of Magnetic Intravitreal Foreign Bodies in 71 Eyes. Ophthalmic Surgery, Lasers & Imaging 2004; 35: 372-378. 21) Soheilian M, Heidari K, Yazdani S, Shahsavari M, Ahmadieh H, Dehghan M, Pattern of uveitis in a tertiary eye care center in Iran. Ocular Immunology and Inflammation 2004; 12: 297-310. 22) Soheilian M, Feghi M, Yazdani S, Anisian A, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Moshfeghi AA, Peyman GA. Surgical management of non-metallic and non-magnetic metallic intraocular foreign bodies. Ophthalmic Surgery, Lasers & Imaging 2005; 36: 189-196. 23) Ahmadieh H, Javadi MA. Cilioretinal artery occlusion following laser in situ keratomileusis. Retina 2005; 25: 533-537. 24) Ramezani AR, Ahmadieh H, Ghaseminejad AK, Yazdani S, Golestan B. Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage; a randomized clinical trial. Br J Ophthalmol 2005; 89: 1041-1044. 25) Ahmadieh H, Moradian S, Faghihi H, Parvaresh MM, Ghanbari H, Mehryar M, Heidari E, Behboudi H, Banaee T, Golestan B. Anatomic and visual outcomes of scleral buckling versus primary vitrectomy in pseudophakic and aphakia retinal detachment six-month follow-up results of a single operation-report, Ophthalmology 2005; 112: 1421-1429. 26) Dehghan MH, Ahmadiah H, Soheilian M, Azarmina M, Mashayekhi A. Therapeutic effects of laser photocoagulation and / or vitrectomy in Eales’ disease. European Journal of Ophthalmology 2005; 15: 379-383. 27) Soheilian M, Mazareei M, Rahmani B, Ahmadieh H, Azarmina M, Dehghan MH, Mashayekhi A, Yazdani S, Moradian S. Outcomes of complex retinal detachment surgery after 1000 and 5000 centistoke silicone oil removals. Annals of Ophthalmology 2005; 37: 253-258. 28) Entezari M, Ahmadieh H, Dehghan MH, Ramezani A, Bassirnia N, Anissian A. Posterior subtenon triamcinolone injection for refractory DME : A Randomized clinical trial. Eur J Ophthalmol 2005; 15: 153-154. 29) Ramezani A, Ahmadieh H, Tabatabaei H. Intravitreal triamcinolone reinjection for refractory diabetic macular edema . Korean Journal of ophthalmology 2006; 20: 156161. 30) Ahmadieh H, Banaee T, Javadi MA, Jafarinasab MR, Yazdani S, Sajadi H. Vitreoretinal disorders in anterior megalophthalmos. Japanese Journal of Ophthalmology 2006; 50: 515-523. 31) Soheilian M, Ghaseminejad A, Yazdani S, Ahmadieh H, Azarmina M, Dehghan MH, Moradian S, Anisian A, Peyman GA. Surgical management of retinal detachment in highly myopic eyes with macular hole. Ophthalmic Surg Laser Imaging 2007; 38: 1522. 32) Ahmadieh H, Moradian S, Malihi M. Rapid regression of extensive retinovitreal neovascularization secondary to branch retinal vein occlusion after a single intravitreal injection of bevacizumab. Int Ophthalmology 2005; 26: 191-193. 33) Ghaseminejad AK, Soheilian M, Anisian A, Ahmadieh H, Azarmina M. Outcomes of surgical treatment for fetinal detachment in highly myopic eyes with macular hole. Iranian Journal of Ophthalmic Research 2006; 1: 17-22. 34) Dehghan MH, Soleimanizad R, Ahmadieh H, Azarmina M, Soheilian M, Moradian S, Sanagou M. Outcomes of lensectomy in hereditary lens subluxation. Iranian Journal of Ophthalmic Research 2006; 1: 92-95. 35) Ghaseminejad AK, Ahmadieh H. Trans-scleral fixation of posterior chamber intraocular lens combined with vitreoretinal surgery. Iranian Journal of Ophthalmic Research 2006; 1: 96-100. 36) Moradian S, Valaee M, Ahmadieh H, Soheilian M, Azarmina M , Dehghan MH, Mashayekhi A, Sanagou M. Outcomes of vitrectomy for non-traumatic non diabetic vitreous hemorrhage. Iranian Journal of Ophthalmology 2007; 2: 46-51. 37) Ahmadieh H, Taei R, Soheilian M, Riazi M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S. Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age related macular degeneration . BMC Ophthalmology 2007 Jun7; 7: 10. 38) Ramezani AR, Tabatabaei H, Ahmadieh H. Diabetic macular edema before and after intravitreal triamcinolone injection. Korean J Ophthalmol 2007; 21: 95-99. 39) Dehghan MH, Ahmadieh H, Ramezani A, Entezari M, Anisian A. A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema. Int Ophthalmol 2008; 28: 7-17. 40) Ahmadieh H, Vafi N . Dramatic response of choroidal neovascularization associated with choroidal osteoma to the intravitreal injection of bevacizumab (Avastin). Graefes Arch Clin Exp Ophthalmol 2007; 245: 1731-1733. 41) Ahmadieh H, Ramezani A, Shoeibi N, Bijanzadeh B, Tabatabaei A, Azarmina M, Soheilian M, Keshavarzi G, Mohebbi MR. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, randomized clinical trial. Graefes Arch Clin Exp Ophthalmol 2008; 246: 483-489. Epub 2007 Oct 5. 42) Soheilian M, Ramezani A, Bijanzadeh B, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Tabatabaei H, Peyman GA . Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema. Retina 2007; 27: 1187-1195. 43) Dehghan MH, Ahmadieh H, Ramezani A, Entezari M, Anisian A. A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema. Int Ophthalmol 2008; 28: 7-17. 44) Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Ahadi H. Single-session photodynamic therapy combined with intravitreal bevacizumab for neovascular agerelated macular degeneration.Eur J Ophthalmol 2008; 18: 297-300. 45) Biau DJ, Halm JA, Ahmadieh H, Capello WN, Jeekel J, Boutron I, Porcher R. Provider and center effect in multicenter randomized controlled trials of surgical specialties: an analysis on patient-level data. Ann Surg 2008; 247: 892-898. 46) Ahmadieh H, Feghhi M, Tabatabaee H, Shoeibi N, Ramezani A, Mohebbi M. Triamcinolone acetonide in silicone – filled eyes as adjunctive treatment for proliferative vitreoretinopathy; A randomized clinical trial . Ophthalmology 2008; 115: 1938-1943 47) Moradian S, Ahmadieh H, Malihi M, Soheilian M, Dehghan MH, Azarmina M. Intravitreal bevacizumab in active progressive proliferative diabetic retinopathy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1699-705. 48) Ramezani A, Ahmadieh H, Azarmina M, Soheilian M, Dehghan MH, Mohebbi MR. Agreement between clinical estimation and a new quantitative analysis by Photoshop software in fundus and angiographic image variables. Int Ophthalmol 2008; 29:439449. 49) Riazi-Esfahani M, Ahmadieh H, Faghihi H, PiriN, Taei R, Karkhaneh R, AlamiHarandi Z , Lashay A , Mirshahi A, Nili-Ahmadabadi M, Soheilian M, Sanagou M. Intravitreal Bevacizumab versus Combined Bevacizumab and Triamcinolone Acetonide for Neovascular Age-Related Macular Degeneration. Journal of Ophthalmic & Vision Research 2008; 3: 95-101. 50) Ahmadieh H. Pharmacotherapy for Age-Related Macular Degeneration. Journal of Ophthalmic & Vision Research (Editorial) 2008; 3: 81-82 51) Soheilian M, Ramezani A, Malihi M, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Peyman GA. Clinical features and surgical outcomes of pediatric rhegmatogenous retinal detachment. Retina 2009; 29:545-551. 52) Javadi MA, Katibeh M, Rafati N, Dehghan MH, Zayeri F, Yaseri M, Sehat M, Ahmadieh H. Prevalence of diabetic retinopathy in Tehran Province: A populationbased study. BMC Ophthalmol 2009; 9:12. 53) Ahmadieh H, Shoeibi N, Entezari M, Monshizadeh R. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial. Ophthalmology 2009; 116: 1943-1948. 54) Soheilian M, Ramezani A, Obudi A, Bijanzadeh B, Salehipour M, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Peyman GA. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema report 2. Ophthalmology 2009; 116: 1142-1150. 55) Akrami H, Soheila Soheili Z, Khalooghi , Ahmadieh H, Rezaie-Kanavi M, Samiei Sh, Davari M, Ghaderi Sh, Sanie-Jahromi F. Retinal Pigment Epithelium Culture; a Potential Source of Retinal Stem Cells. J Ophthalmic Vis Res 2009; 4:134-141. 56) Daftarian N, Dehghan MH, Ahmadieh H, Soheilian M, Karkhaneh R, Lashay A, Mirshahi A, Parhizkar H, Kazemimoghadam M, Modarreszadeh M, HashemiM, Fadaei M, Entezari M. Characteristics and surgical outcomes of rhegmatogenous retinal detachment following myopic LASIK. Journal of Ophthalmic & Vision Research 2009; 4: 151-159. 57) Dehghan MH, Ahmadieh H, Soheilian M, Azarmina M, Moradian S, Ramezani AR, Tavallal A, Naghibozakerin J. Effect of oral prednisolone on visual outcomes and complications after scleral buckling. Eur J Ophthalmol 2010; 20:419-423. 58) Entezari M, Ramezani A, Ahmadieh H, Bakhtiari P, Yaseri M, Soltani K. Cryotherapy of sclerotomy sites for prevention of late post-vitrectomy diabetic hemorrhage: a randomized clinical trial..Graefes Arch Clin Exp Ophthalmol 2010; 248:13-19. 59) Nourinia R, Jabbarpour Bonyadi MH, Ahmadieh H. Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration. J Ophthalmic Vis Res 2010; 5:168-174. 60) Ramezani Ar, Dehghan MH, Rostami A, Ahmadieh H, Entezari M, Soheilian M, Azarmina M, Moradian S, Yaseri M. Outcomes of Retinal Detachment Surgery in Eyes with Chorioretinal Coloboma. J Ophthalmic Vis Res 2010; 5: 240-245. 61) Nikkhah H, Ramezani A, Ahmadieh H, Soheilian M, Azarmina M, Dehghan MH, Moradian S, Nourinia R. Childhood pars planitis; clinical features and outcomes. J Ophthalmic Vis Res 2011; 6:249-254. 62) Shoeibi N, Ahmadieh H, Abrishami M, Poorzand H. Rapid and sustained resolution of serous retinal detachment in Sturge-Weber syndrome after single injection of intravitreal bevacizumab. Ocul Immunol Inflamm 2011; 19:358-360. 63) Bagheri A, Erfanian-Salim R, Ahmadieh H, Nourinia R, Safarian O, Yazdani S. Globe perforation during strabismus surgery in an animal model: Treatment versus observation. J AAPOS 2011; 15:144-147. 64) Rajavi Z, Katibeh M, Ziaei H, Fardesmaeilpour N, Sehat M, Ahmadieh H, Javadi MA. Rapid assessment of avoidable blindness in Iran. Ophthalmology 2011; 118:18121818. 65) Ahmadieh H, Taei R, Riazi-Esfahani M, Piri N, Homayouni M, Daftarian N, Yaseri M. Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial. Retina 2011; 31:1819-1826. 66) Moradian S, Faghihi H, Sadeghi B, Piri N, Ahmadieh H, Soheilian M, Dehghan MH, Azarmina M, Esfahani MR. Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion with macular edema: results at 3 months (Report 1). Graefes Arch Clin Exp Ophthalmol2011; 249:193-200. 67) Akrami H, Soheili ZS, Sadeghizadeh M, Khalooghi K, Ahmadieh H, Kanavi MR, Samiei S, Pakravesh J. Evaluation of RPE65, CRALBP, VEGF, CD68, and tyrosinase gene expression in human retinal pigment epithelial cells cultured on amniotic membrane. Biochem Genet 2011; 49:313-322. 68) Ghaderi S, Soheili ZS, Ahmadieh H, Davari M, Jahromi FS, Samie S, Rezaie-Kanavi M, Pakravesh J, Deezagi A. Human amniotic fluid promotes retinal pigmented epithelial cells' trans-differentiation into rod photoreceptors and retinal ganglion cells. Stem Cells Dev 2011; 20:1615-1625. 69) Sanie-Jahromi F, Ahmadieh H, Soheili ZS, Davari M, Ghaderi S, Kanavi MR, Samiei S, Deezagi A, Pakravesh J, Bagheri A. Enhanced generation of retinal progenitor cells from human retinal pigment epithelial cells induced by amniotic fluid. BMC Res Notes 2012; 5:182. 70) Zahabi A, Shahbazi E, Ahmadieh H, Hassani SN, Totonchi M, Taei A, Masoudi N, Ebrahimi M, Aghdami N, Seifinejad A, Mehrnejad F, Daftarian N, Salekdeh GH, Baharvand H. A new efficient protocol for directed differentiation of retinal pigmented epithelial cells from normal and retinal disease induced pluripotent stem cells. Stem Cells Dev 2012; 21:2262-2272. 71) Ahmadieh H, Shoeibi N. Bevacizumab, vitrectomy, and vitreous hemorrhage. Ophthalmology 2013; 120:219-220. 72) Ahmadieh H, Nourinia R, Hafezi-Moghadam A.Intravitreal Fasudil Combined With Bevacizumab for Persistent Diabetic Macular Edema: A Novel Treatment. JAMA Ophthalmol. 2013 May 2:1-2. doi:10.1001/jamaophthalmol.2013.143. [Epub ahead of print] No abstract available. 73) Entezari M, Ramezani A, Ahmadieh H, Ghasemi H.Batch-related sterile endophthalmitis following intravitreal injection of bevacizumab. Indian J Ophthalmol. 2013 Apr 26. [Epub ahead of print] 74) Soufi FG, Mohammad-Nejad D, Ahmadieh H. Resveratrol improves diabetic retinopathy possibly through oxidative stress - nuclear factor κB - apoptosis pathway. Pharmacol Rep. 2012; 64:1505-14. 75) Nourinia R, Soheili ZS, Ahmadieh H, Akrami H, Rezaei Kanavi M, Samiei S. Knockdown of the Placental Growth Factor Gene Inhibits Laser Induced Choroidal Neovascularization in a Murine Model. J Ophthalmic Vis Res 2013; 8: 4-8. 76) Zhang ZH, Liu HY, Hernandez-Da Mota SE, Romano MR, Falavarjani KG, Ahmadieh H, Xu X, Liu K.Vitrectomy with or without preoperative intravitreal bevacizumab for proliferative diabetic retinopathy: a meta-analysis of randomized controlled trials. Am J Ophthalmol. 2013 Jul; 156(1):106-115. 77) Nourinia R, Ahmadieh H, Shahheidari MH, Zandi S, Nakao S, Hafezi-Moghadam A. Intravitreal fasudil combined with bevacizumab for treatment of refractory diabetic macular edema; a pilot study. J Ophthalmic Vis Res. 2013 Oct; 8(4):337-40. 78) Davari M, Soheili ZS, Ahmadieh H, Sanie-Jahromi F, Ghaderi S, Kanavi MR, Samiei S, Akrami H, Haghighi M, Javidi-Azad F. Amniotic fluid promotes the appearance of neural retinal progenitors and neurons in human RPE cell cultures. Mol Vis. 2013 Nov 17; 19:2330-42. 79) Shoeibi N, Ahmadieh H, Entezari M, Yaseri M. Intravitreal Bevacizumab with or without Triamcinolone for Refractory Diabetic Macular Edema: Long-term Results of a Clinical Trial. J Ophthalmic Vis Res. 2013 Apr; 8(2):99-106. 80) Sun D1, Nakao S2, Xie F1, Zandi S2, Bagheri A3, Rezaei Kanavi M3, Samiei S4, Soheili ZS5, Frimmel S2, Zhang Z6, Ablonczy Z7, Ahmadieh H3, Hafezi-Moghadam A8. Molecular imaging reveals elevated VEGFR-2 expression in retinal capillaries in diabetes: a novel biomarker for early diagnosis. FASEB J. 2014 Jun 5. 81) Ahmadieh H1, Nourinia R, Ragati Haghi A, Ramezani A, Entezari M, Rahmani G, Yaseri M. Oral colchicine for prevention of proliferative vitreoretinopathy: a randomized clinical trial. Acta Ophthalmol. 2014 Apr 23 82) Feizi S, Soheili ZS, Bagheri A, Balagholi S, Mohammadian A, Rezaei-Kanavi M, Ahmadieh H, Samiei S, Negahban K. Effect of amniotic fluid on the in vitro culture of human corneal endothelial cells. Exp Eye Res. 2014 May; 122:132-40. 0.1016/j.exer.2014.04.002. 83) Ahmadieh H, Azar ST. The role of incretin-based therapies in prediabetes: A review. Prim Care Diabetes. 2014 Mar 22. Pii: S1751-9918(14)00037-0. 84) Nourinia R1, Ahmadieh H1, Rezaei-Kanavi M1, Shoeibi N2, Kamrava K1, Karimi S. Safety of Intravitreal Zoledronic Acid, an Anti-angiogenic Bisphosphonate, in a Rat Model. J Ophthalmic Vis Res. 2014 Jan; 9(1):44-9. 85) Mansour AM, Arevalo JF, Al Kahtani E, Zegarra H, Abboud E, Anand R, Ahmadieh H, Sisk RA, Mirza S, Tuncer S, Navea Tejerina A, Mataix J, Ascaso FJ, Pulido JS, Guthoff R, Goebel W, Roh YJ, Banker AS, Gentile RC, Martinez IA, Morris R, Panday N, Min PJ, Mercé E, Lai TY, Massoud V, Ghazi NG. Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma. J Ophthalmol. 2014; 2014:210458. 86) Dehghan MH, Katibeh M, Ahmadieh H, Nourinia R, Yaseri M. Prevalence and Risk Factors for Diabetic Retinopathy in the 40 to 80 year-old Population in Yazd, Iran - The Yazd Eye Study. 2015 Jan;7(1):139-41. 87) Piri N, Ahmadieh H, Taei R, Soheilian M, Karkhaneh R, Lashay A, Golbafian F, Yaseri M, Riazi-Esfahani M Photodynamic Therapy and Intravitreal Bevacizumab with Versus without Triamcinolone for Neovascular Age-related Macular Degeneration; a Randomized Clinical Trial. J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):469-77. 88) Ahmadieh H.Erratum: combined conjunctival autograft and overlay amniotic membrane transplantation; a novel surgical treatment for pterygium: erratum. J Ophthalmic Vis Res. 2014 Oct-Dec;9(4):526. 89) Azarmina M, Soheilian M, Ahmadieh H, Azarmina H. Electroretinogram changes in the sound eye of subjects with unilateral necrotizing herpetic retinitis. J Ophthalmic Vis Res. 2014 Apr;9(2):195-203. 90) Mansour AM, Arevalo JF, Al Kahtani E, Zegarra H, Abboud E, Anand R, Ahmadieh H, Sisk RA, Mirza S, Tuncer S, Navea Tejerina A, Mataix J, Ascaso FJ, Pulido JS, Guthoff R, Goebel W, Roh YJ, Banker AS, Gentile RC, Martinez IA, Morris R, Panday N, Min PJ, Mercé E, Lai TY, Massoud V, Ghazi NG. Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma. J Ophthalmol. 2014; 2014:210458. 91) Nourinia R, Ahmadieh H, Rezaei-Kanavi M, Shoeibi N, Kamrava K, Karimi S.Safety of Intravitreal Zoledronic Acid, an Anti-angiogenic Bisphosphonate, in a Rat Model.J Ophthalmic Vis Res. 2014 Jan; 9(1):44-9. 92) Heidari R, Soheili ZS, Samiei S, Ahmadieh H, Davari M, Nazemroaya F, Bagheri A, Deezagi A. Alginate as a cell culture substrate for growth and differentiation of human retinal pigment epithelial cells. Appl Biochem Biotechnol. 2015 Mar; 175(5):2399-412. 93) Ghadiri Soufi F, Arbabi-Aval E, Rezaei Kanavi M, Ahmadieh H.Anti-inflammatory properties of resveratrol in the retinas of type 2 diabetic rats. Clin Exp Pharmacol Physiol. 2015 Jan; 42(1):63-8. 94) Katibeh M, Blanchet K, Akbarian S, Hossaini S, Ahmadieh H, Burton MJ. "Planning eye health services in Varamin district, Iran: a cross-sectional study". BMC Health Serv Res. 2015 Apr 3; 15(1):140. [Epub ahead of print] 95) Bagheri A, Soheili ZS, Ahmadieh H, Samiei S, Sheibani N, Astaneh SD, Kanavi MR, Mohammadian A. Simultaneous application of bevacizumab and anti-CTGF antibody effectively suppresses proangiogenic and profibrotic factors in human RPE cells.Mol Vis. 2015 Apr 10; 21:378-90. 96) Bonyadi MH, Bonyadi M, Ahmadieh H, Fotuhi N, Shoeibi N, Saadat S, Yagubi Z.Tumor Necrosis Factor Gene Polymorphisms in Advanced Non-exudative Age-related Macular Degeneration. J Ophthalmic Vis Res. 2015 Apr-Jun; 10(2):155-9. 97) Dehghan MH, Katibeh M, Ahmadieh H, Nourinia R, Yaseri M. Prevalence and risk factors for diabetic retinopathy in the 40 to 80 year-old population in Yazd, Iran: the Yazd Eye Study. J Diabetes. 2015 Jan;7(1):139-41. 98) Sanjari N, Pakravan M, Nourinia R, Esfandiari H, Hafezi-Moghadam A, Zandi S, Nakao S, Shah-Heidari MH, Jamali A, Yaseri M, Ahmadieh H. Intravitreal injection of a Rho-kinase inhibitor (fasudil) for recent onset non-arteritic anterior ischemic optic neuropathy. J Clin Pharmacol. 2015 Oct 7. 99) Ahmadieh H, Nourinia R, Ragati Haghi A, Ramezani A, Entezari M, Rahmani G, Yaseri M.Oral colchicine for prevention of proliferative vitreoretinopathy: a randomized clinical trial. Acta Ophthalmol. 2015 Mar;93(2):e171-2. Local papers 1) Ahmadieh H., Bagheri A, Javadi MA., Karimian F., Dehghan MH., Mashyekhi A., Soheilian M., Sajjadi H., Azarmina M. Epidemiological and clinical characteristics of pars planitis in Labbafinejad Medical Center. Bina 1996; 1: 12-22. 2) Mashyekhi A, Ahmadieh H, Fatemi SA. Chronic uveitis in elderly. Bina 1996; 1: 6568. 3) Ahmadieh H. Giant retinal tear (Editorial). Bina 1996; 2: 5-8. 4) Mashyekhi A, Ahmadieh H, Soheilian M, Dehghan MH, Azarmina M, Valaee N. Evaluation of the results of vitrectomy surgery in management of giant retinal tears. Bina 1996: 2: 13-27. 5) Azarmina M, Ahmadieh H, Soheilian M, Dehghan MH, Mashayekhi A, Valaee N.Argon laser photocoagulation (ALP) for treatment of early stages of retinal angiomatosis in Von Hipple disease (V.H.). Bina 1997; 2: 250-254. 6) Dehghan MH, Sedighi A, Ahmadieh H, Azarmina M, Soheilian M, Mashayekhi A, Sedighi AS. Evaluation of the results of laser treatment of diabetic macular edema. Bina 1998; 3: 192-200. 7) Ahmadieh H, Jafarinasab MR, Sajjadi H, Javadi MA, Azarmina M, Soheilian M. Long term follow-up of pars plana lensectomy and vitrectomy for complicated cataract in Juvenile rheumatoid arthritis. Bina 1998; 3: 300-308. 8) Behboodi H, Ahmadieh H, Soheilian M, Sajjadi H, Dehghan MG, Azarmina M, Valaee N. Natural course and manifestations of Vogt- Koyanagi-Harada Syndrome and effectiveness of medical and surgical treatment of these cases. Bina 1998; 4: 26-33. 9) Ahmadieh H. Pars planitis. Bina 1998; 4: 44-50. (Review) 10) Azarmina M, Abrishami M, Ahmadieh H, Soheilian M, Dehghan MH, Mashayekhi A. Results of medical therapy on visual acuity and optic nerve in patients with methyl alcohol poisoning Bina 1999; 4: 26-33. 11) Jenaban SA, Javadi MA, Ahmadieh H.Unilateral panuveitis in a young girl. Bina 1999; 4: 160-167. 12) Soheilian M, Mazaree M, Rahmani B, Ahmadieh H, Azarmina M, Dehghan MG, Mashayekhi A. Outcome of complex retinal detachment surgery after silicone oil removal (silicone oil 5000 cs versus 1000 cs). Bina 1999; 4: 327-334. 13) Ahmadieh H, Dadgostar A. Visual outcomes following cataract extraction in vitrectomized eyes in Labbafinejad Medical Center (1993-1999). Bina 2000; 5: 205212. 14) Dehghan MG, Rabanikhah Z, Ahmadieh H, Azarmina M, Soheilian M, Mashayekhi A. Prophylactic treatment in the fellow eye of the patients undergoing scleral buckling. Bina 2000; 5: 213-219. 15) Dehghan MH, Ahmadieh H, Aghadoust D. Bilateral acute retinal necrosis syndrome following herpetic encephalitis. Bina 2000; 6: 71-76. 16) Dehghan MH, Malihi M, Ahmadieh H, Azarmina M, Soheilian M, Mashayekhi A. Macular photocoagulation in choroidal neovascularization. Bina 2001; 6: 125-131. 17) Bagheri A, Etezad-Razavi M, Ahmadieh H, Abrishami M. Results of strabismus surgery after scleral buckling procedure in Labbafinejad Medical Center (19932000). Bina 2001;6: 151-157. 18) Soheilian M, Abolhasani A, Ahmadieh H, Azarmina M, Dehghan M, Mashayekhi A, Siadat F. External magnet versus intraocular forceps for intravitreal foreign body extraction. Bina 2002; 7: 221-229. 19) Azarmina M, Nazari R, Valaee N, Mashayekhi A, Ahmadieh H, Soheilian M, Dehghan M. Minimal surgery scleral buckling. Bina 2002; 7: 212-220. 20) Dehghan M.H., Ahmadieh H., Soheilian M., Azarmina M., Mashayekhi A., Naghibozakerin J. Therapeutic effects of laser photocoagulation and vitrectomy in Eales ’disease. Medical Journal of the Islamic Republic of Iran 2003; 17: 21) Ramezani AR, Tabatabaie H, Ahmadieh H. Reinjection of intravitreal triamcinolone for refractory diabetic macular edema. Bina 2005; 11: 91-98. 22) Ahmadieh H, Dehghan MH, Ramezani AR, Yasdani S, Mohebbi MR. Confounding factors on the effect of intravitral triamcinolone for refractory diabetic macular edema. Bina 2005; 11: 164-175. 23) Dehghan MH, Feghhi M, Ahmadieh H, Soheilian M, Azarmina M, Moradian S, Ramezani AR, Tavallali A. Effect of oral prednisolone on visual outcomes and complications after scleral bukling. Bina 2005; 11: 176-182. 24) Moradian S, Valaee M, Ahmadieh H, Soheilian M, Azarmina M, Dehghan MH, Mashayekhi A, Sanagou M. Causes and results of vitrectomy for spontaneous Nondiabetic vitreous hemorrhage. Bina 2006; 11: 470-478. 25) Dehghan MH, Soleimanzad R, Ahmadieh H, Azarmina M, Soheilian M, Moradian S, Sanagou M. Clinical aspects and results of lensectomy in hereditary lens subluxation. Bina 2006; 11: 484-488. 26) Moradian M, Ghadiri B, Ahmadieh H, Soheilian M, Azarmina M, Dehghan MH, Mashayekhi A, Sanagou M. Results of Vitrectomy in Idiopathic Macular Hole. Bina 2006; 12: 14-22. 27) Golestan B, Rennolls K, Mohammad K, Ahmadieh H, Moradian S. Eternal weibull regression analysis for evaluation of the effects of different covariates on retinal redetachment following retinal detachment surgery. Bina 2006; 12: 28-36. 28) Moradian S, Rahimi A, Ahmadieh H, Soheilian M, Dehghan MH, Azamina M. Viterectomy with internal limiting membrane peeling in acute central retinal vein occalusion presenting with low vision. Bina 2009; 14: 229-234. 29) Ahmadieh H, Homayooni M. Role of vascular endothelial growth factors in ocular neovascular diseases. Bina 2009; 14: 298-307. 30) Bagheri A, Erfanian Salim R, Ahmadieh H, Noorinia R, Safarian O, Karimi S. Cryopexy or Laser Therapy versus Observation for Management of Accidental Scleral Perforation during Strabismus Surgery; An Experimental Study. Bina 2010; 15: 193198. 31) Malihi M, Soheilian M, Ramezani AR, Rostami P, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S. Clinical Features and Surgical Outcomes of Pediatric Rhegmatogenous Retinal Detachment. Bina 2010; 16:42-50. 32) Janani L,Moradian S, Ahmadieh H,Mohammad K, Golestan B, Forouzanfar MH. Propensity Score Analysis for Comparing Primary Vitrectomy with and without Encircling Band in Pseudophakic / Aphakic Retinal Detachment. Bina 2010; 16: 100107. 33) Rajavi J, Katibeh M, Ziaei H, Fardesmailipour N, Ahmadieh H, Javadi MA. Prevalence and causes of blindness and visual impairment in varamin district. Bina 2011; 16:179. 34) Ahmadieh. H, Kamrava K. Fluctuation of Vision in Best Vitelliform Macular Dystrophy, a Case Report. Bina 2012; 18: 92-96. 35) Dehghan MH, Katibeh M, Ahmadieh H, Ramezani AR, Moradian S, Noorinia R, Ziaei H, Mahdavi AR, Yaseri M, Naghib J, Toosi A, Azarmina M, Roohi K, Javadi MA. Prevalence and Risk Factors of Diabetic Retinopathy in Yazd Province. Bina 2013; 18 (4): 375-391. International Congresses * International Congress of Ophthalmology. Singapore, March 1990. 1. Ahmadieh H., Sajjadi H., Azarmina M., Faghihi H. Vitrectomy in chronic uveitis. * 2nd Congress on Immunointervention in Autoimmune Diseases, Paris, 1991. 1. Sajjadi H., Soheilian M., Ahmadieh H., Hassanein K., Parvin M., Azarmina M., Ehyaee V., Amiransari B. Low-dose cyclosporin-A Therapy in Behcet’s disease. * 2nd International Symposium on Ocular Trauma, Geneva, 1992. 1. Ahmadieh H., Soheilian M., Sajjadi H., Azarmina M., Abrishami M. Vitrectomy in ocular trauma-factors influencing final visual outcome. 2. Ahmadieh H., Sajjadi H., Azarmina M., Soheilian M., Baharivand N. Surgical management of intraretinal foreign bodies. * Xth Congress European Society of Ophthalmology June 25-29, 1995, Milan, Italy. 1. Ahmadieh H, Azarmina M, Javadi MA, Jaafari Nasab MR. Long term follow-up of pars plana lensectomy and vitrectomy for complicated cataract in juvenile rheumatoid arthritis. 2. Ahmadieh H,Entezari M, Sajjadi H, Soheilian M. The factors influencing the anatomic and visual results in retinal reattachment surgery. 3. Ahmadieh H., Dehghan M.H., Azarmina M., Sajjadi H., Zare M., Eales’disease: The results of laser therapy and vitrectomy. 4. Ahmadieh H, Bagheri A, Soheilain M, Azarmina M. HLA typing and blood groups in pars planitis. * XXth Meeting of the Club Jules Gonin & 29th Anuual Scientific Session of the Retina Society, September 1-6, 1996, Bern Switzerland. 1. Ahmadieh H, Soheilian M, Azarmina M, Dehghan MH, Mashayekhi A, Derakhshandeh J. Repair of complicated retinal detachment secondary to acute retinal necrosis. * Centennial Annual Meeting of American Academy of Ophthalmology, October 2731, 1996, Chicago, IL. 1. Ahmadieh H, Javadi MA, Karimian F, Einollahi B, Ahmady M, Valaei N, Zare M. Primary capsulectomy and anterior vitrectomy combined with lensectomy PCIOL implantation in children: Limbal vs. pars plana approach. 2. Ahmadieh H, Bagheri A, Javadi MA, Soheilian M, Sajjadi SH, Karimian F, Azarmina M. The association of endoteliitis with pars planitis. * Annual Meeting of American Academy of Ophthalmology, October 26-29, 1997, San Franscisco, CA. 1. Soheilian M, Dastmehr S, Rahmani B, Ahmadieh H, Azarmina M, Dehghan MH,Mashayekhi A, Sajjadi H. Outcome of surgical (pars plicata lensectomy and vitrectomy) and nonsurgical management of PHPV. * XXIst Meeting of the Club Jules Gonin, 28 August- 1 September, 1998, EdinburghScotland. 1. Ahmadieh H, Emamjomeh A, Sajjadi H, Soheilian M, Azarmina M, Dehghan MH, Mashayekhi, A. Vitreoretinal surgery in pars planitis. 2. Ahmadieh H, Soheilian M, Azarmina M, Dehghan MH, Mashayekhi, A. Transscleral fixation of posterior chamber intraocular lens combined with vitreoretinal surgery. * Annual Meeting of American Academy of Ophthalmology, November 8-11, 1998, New Orleans, LA. 1. Ahmadieh H, Rezaei M., Javadi MA., Sajjadi H., Jafari M. Retinal detachment in patients with macular corneal dystrophy. 2. Soheilian M, Mazarei M, Rahmani B, Ahmadieh H, Azarmina M, Dehghan MH, Mashayekhi A. Outcome of complex retinal detachment (RD) surgery after oil removal (SOR) [silicone oil (SO) 5000Cs vs. 1000Cs]. * XXVIIIth International Congress of Ophthalmology, June 21- 26, 1998, Amsterdam - The Netherlands. 1. Ahmadieh H, Azarmina M, Soheilian M, Dehghan MH, Mashayekhi A. Argon laser photocoagulation for treatment of early stages of retinal angiomatosis in Von Hippel disease * Annual Meeting of American Academy of Ophthalmology, October 24-27, 1999, Orlando, Florida. 1. Soheilian M, Mirdehghan A, Ahmadieh H. Combined phaco + total vitrectomy and PCIOL for management of uveitic cataract. 2. Ahmadieh H, Jafarinasab MR, Soheilian M, Sajadi H, Azarmina M, Javadi MA.Long term follow up of pars plana lensectomy and vitrectomy for complicated cataract in juvenile rheumatoid arthritis. * The Annual Meeting of American Academy of Ophthalmology, October 22-25, 2000, Dalas, Texas. 1. Azarmina M, Ahmadieh H, Abrishami M, Soheilian M, Dehghan MH, Mashayekhi A. Visual outcome following medical therapy for toxic optic neuropathy due to methyl alcohol poisoning. * XXIInd Meeting of the Club Jules Gonin, September 2 - 6, 2000, Taormina, Italy. 1. Ahmadieh H, Banaee T, Javadi MA, Jafarinasab MR. Vitreoretinal disorders in anterior megalophthalmos 2. Ahmadieh H, Soheilian M. Vitreoretinal surgery in pars planitis: a posterior segment triple procedure (video) * International Forum on Diabetic Retinopathy, September 7-9, 2000, Naples,Italy. 1. Ahmadieh H, Aghadoust D, Soheilian M, Azarmina M, Dehghan MH, Mashayekhi A. Early vitrectomy in patients with active progressive diabetic retinopathy and useful vision. * XIX Congress of the ESCRS, September 1-5, 2001 Amsterdam, the Netherlands. 1. Ahmadieh H, Ghaseminejad AK, Soheilian M, Azarmina M, Dehghan MH, Mashayekhi A. Transscleral fixation of posterior chamber intraocular lens combined with vitreoretinal surgery. 2. Ahmadieh H, Javadi MA. Dadgoster A. Cataract surgery in vitrectomized eyes. * Annual Meeting of American Academy of Ophthalmology, October 20-23, 2002, Orlando, Florida. 1. Dehghan MH, Ahmadieh H, Soheilian M, Azarmina M, Mashayekhi A, Naghibozzakerin J. Therapeutic effects of laser photocoagulation and vitrectomy in Eales’ disease. * Meeting of American Academy of Ophthalmology, November 15-18, 2003, Anaheim, California. 1. Ahmadieh H., Moradian S., Faghihi H., Parvaresh M.M., Ghanbari H., Heidari E., Mehryar M., Behboudi H., Banaei T., Entezari M., Golestan B., Soori H., Anisian A. Visual and anatomic outcome of scleral buckling vs primary vitrectomy in aphakic and pseudophakic retinal detachment. 2. Ahmadieh H., Soheilian M., Karkhaneh R., Parvaresh M.M., Dehghan M.H., Parhizkar H., Lashay A.R., Kazemimoghadam M., Mirshahi A., Modarreszadeh M., Hashemi M., Mehrazma M., Fadaei M., Ghanbari H., Behboudi H., Mehryar M., Entezari M. Rhegmatogenous retinal detachment following LASIK. * 7th Vitreoretinal Symposium, June 4-5, 2004, Marburg, Germany (Guest. Speaker). 1. Ahmadieh H., Retinal complications of LASIK. 2. Ahmadieh H., Visual and anatomic outcome of scleral buckling vs primary vitrectomy in aphakic and pseudophakic retinal detachment. * 22nd Annual Meeting of American Society of Retina Specialists, August 16-20, 2004, San Diego, California. 1. Ahmadieh H., Dehghan M.H., Ramezani A, R., Entezari M., Mohebbi M.R., Anissian A. A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for treatment of refractory diabetic macular edema. 2. Ahmadieh H., Rotating intraocular foreign body * Annual Meeting of American Academy of Ophthalmology, October 23-26, 2004, New Orleans, U.S.A. 1. Soheilian M., Aletaha M., Yazdani S., Ahmadieh H., Azarmina M.,Peyman G.A.,Medical and surgical management of pediatiric VogtKoyanagi-Harada-associated panuveitis * Annual Meeting of EVRS, September, 2004, Istanbul, Turkey. 1. Ramezani A.R., Ahmadieh H., Ghasemnejad A.K., Golestan B., Effect of tranexamic acid on early postvitrectomy diaetic hemorrhage. 2. Entezari M., Ahmadieh H., Dehghan M.H., Ramezani A.R., Bassirinia N., Anissian A., Posterior subtenon triamcicolone injection for refractory diabetic macular edema; a randomized clinical trial 3. Dehghan M.H., Ahmadieh H., Ramezani A.R., Entezari M., Anissian A., Mohebbi M.R., Intravitreal triamcinolone for refractory diabetic macular edema; a randomized clinical trial. * 15th Congress European Society of Ophthalmology (SOE) September 25-29, 2005, Berlin, Germany (Invited speaker). 1. Ahmadieh H., Primary vitrectomy versus scleral buckling in management of pseudophakic and aphakic retinal detachment: results of Iranian PARD study. * Annual Meeting of American Academy of Ophthalmology, Chicago, October 15-18, 2005. 1. Ahmadieh H., Tabatabaei H., Feghhi M., Papi A., Ramezani A.R., Banaee T. Effect of triamcinolone acetoide on progression of proliferative vitreoretinopathy in silicone-filled eyes: a randomized clinical trial * Cannes Retina Festival: The 24th Annual Meeting of ASRS and the 6th Annual Meeting of EVRS, France, September 9, 2006. 1. Ahmadieh H., Tabatabaei H., Feghi M., Papi A., Ramezani A., Banaee T. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy; a randomized clinical trial. 2. Ramezani A. Tabatabaei H., Ahmadieh H. Diabetic macular edema before and after intravitreal triamcinolone injection. 3. Moradian S., Ahmadieh H. Demographic characteristic and risk factors of pseudophakic and aphakic retinal detachment. 4. Ahmadieh H., Soheilian M., Azarmina M., Dehghan M.H., Moradian S. Intraretinal foreign bodies: clinical features and surgical outcomes. * 50 th Meeting of SOE Vienna, Austria, June: 9-12, 2007. 1. Ahmadieh H., Ramezani A.R., Bijanzadeh B., shoeibi N., Tabatabaei A., Keshavarzi G.R., Soheilian M. Dehghan M.H. Moradian S. Azarmina M. Tabatabaee H. Entezari M. Farahvash M.S. Mohebbi M.R. A multicenter placebo – controlled randomized clinical trial to compare bevacizumab versus combined bevacizumab and triamcinolone for refractory diabetic macular edema: six –week results. * Annual Meeting of American Academy of Ophthalmology, New Orleans, November 10-13, 2007. 1. Ahmadieh H, Homayouni M, Taei R.Combined photodynamic therapy and intravitreal bevacizumab with or without triamcinolone for retinal angiomatous proliferation. 2. Ahmadieh H , Taei R, Soheilian M , Riazi EsfahaniM , Karkhaneh R , Lashay AR, YaseriM.Combined single-session photodynamic therapy and intravitreal bevacizumab with or without triamcinolone in neovascular AMD: a randomized clinical trial. 3. Moradian S, Riazi EsfahaniM , Ahmadieh H , Soheilian M, Dehghan MH , Azarmina M , Faghihi Habibabadi H , Karkhaneh R , Lashay AR, Piri N , Aalami Z , Sadeghi B . Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion: a randomized clinical trial 4. Soheilian M, Kiavash V , Rabbanikhah Z , Alizadeh Ghavidel L , Ramezani AR, Ahmadieh H , Azarmina M , Dehghan MH , Moradian S , Peyman GA. Intravitreal bevacizumab vs. triamcinolone for refractory cystoid macular edema in chronic uveitis: a randomized Cclinical trial . 5. Taei R, Ahmadieh H, Riazi Esfahani M, Piri N, Soheilian M, Dehghan MH, Azarmina M Moradian S. Intravitreal bevacizumab compared with combined bevacizumab and triamcinolone in neovascular AMD: six-month results of a clinical trial. 6. Faghihi Habibabadi H , Moradian S, Piri N, Riazi Esfahani M, Aalami Z, Karkhaneh R, Tabatabaei A , Lashay AR, Ahmadieh H , Soheilian M . Intravitreal bevacizumab vs. combination of bevacizumab and triamcinolone vs. Sham treatment for central retinal vein occlusion . * Annual Meeting of American Academy of Ophthalmology, November 8 - 11, 2008; Atlanta, Georgia 1. Soheilian M, Ramezani A, Obudi A, Yaseri M, Salehipour M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Peyman G. Long-term results of a randomized trial comparing intravitreal bevacizumab alone or combined with triamcinolone vs. macular photocoagulation as a primary treatment. 2. Entezari M, Ramezani AR, Ahmadieh H , Bakhtiari P, Yaseri M. Cryotherapy of sclerotomy sites for prevention of late post-vitrectomy diabetic hemorrhage: A randomized clinical trial. 3. Ahmadieh H, Shoeibi N, Entezari M. intravitreal bevacizumab for early post-vitrectomy hemorrhage in diabetics: A randomized, double- masked clinical trial 4. Soheilian M , Ramezani AR, MalihiM , Ahmadieh H, Azarmina M , Dehghan MH , Moradian S , Peyman GA . Clinical features and surgical outcomes of pediatric rhegmatogenous retinal detachment. 5. Ahmadieh H , Shoeibi N , Entezari M , Yaseri M. intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema: long-term results of a clinical trial. 6. Ahmadieh H , Nourinia R. intravitreal expansile gas followed by intravitreal bevacizumab for submacular hemorrhage secondary to neovascular AMD. 7. Faghihi Habibabadi H , Moradian S , Piri N , Riazi Esfahani M , Aalami Z, R Lashay AR , Tabatabaei A , Karkhaneh R , Ahmadieh H , Soheilian M, Sadeghi B. intravitreal bevacizumab vs. combination of bevacizumab and triamcinolone vs. sham treatment in central retinal vein occlusion. * Annual Meeting of American Academy of Ophthalmology, October 23, 2009 October 28, 2009,San Francisco, CA. 1. Moradian S, Faghihi H, Ahmadieh H, Sadeghi B, Piri N, Soheilian M, Dehghan MH, Brancato LJ, Riazi Esfahani M. Intravitreal bevacizumab vs. sham treatment in acute branch retinal vein occlusion: A multicenter clinical trial. 2. Moradian S, Ahmadieh H, Faghihi H, Ramezani A, Entezari M, Banaee T, Heidari E, Behboodi H, Mahmoodi AH, Yaseri M. Anatomic and visual outcomes of 4 surgical techniques in pseudophakic and aphakic retinal detachment: A multicenter clinical trial. * Asia-ARVO Meeting, January 15-18, 2009, Heydarabad, India 1. Homayounii M, Ahmadieh H, Taei R, Soheilian M, Riazi M, Karkhaneh R, Lashay A, Yaseri M. Combained single-session photodynamic therapy and intravitreal bevacizumab with vs. without triamcinolone in neovascular AMD: A randomized clinical trial. *Annual Meeting of American Academy of Ophthalmology, Chicago, U.S.A, 16_19 October 2010. 1. Entezari M, Ramezani AR,Ahmadieh H, Ghassemi Khourinia H. Batch- Related Sterile Endophthalmitis Following Intravitreal Injection of Bevacizumab. 2. Nikkhah H, Ahmadieh H, Ramezani AR, Soheilian M, Azarmina M, Dehghan MH, Moradian S. Childhood Onset Pars Planitis: Clinical Features and Outcomes. 3. Ahmadieh H, Banaee T, Behboudi H, Ramezani AR, Movaseghi M, Entezari M, Yaseri M. Combined 5-Flourouracil,Low Molecular Weight Heparin, Dexamethasone and Oral Colchicine for Established Proliferative Vitreoretinopathy: A Clinical Trial. 4. Ahmadieh H, Moradian S, Nourinia R, Jabbarpour Bonyadi MH, Yaseri M. Intravitreal Bevacizumab as an Adjunctive Treatment for High-risk Proliferative Diabetic Retinopathy. 5. Nourinia R, Ahmadieh H, soheili S, Akrami H, Rezaei Kanavi M. Knockdown of the Placental Growth Factor Gene Inhibits Laser-Induced Choroidal Neovascularization. 6. Rajavi ZH, KatibehM, Ziaei H, Fard Esmaeil Pour N, Sehat M, Ahmadieh H, Javadi MA. Rapid Assessment of Avoidable Blindness in Iran. 7. Moradian S, Faramarzi A, Kanaani A, Ahmadieh H, Soheilian M, Dehghan MH, Azarmina M. The Effect of Topical Umbilical Cord Serum on Healing of Corneal Epithelial Defect Created During Diabetic Vitrectomy. 8. Ramezani AR, Entezari M, Moradian S, Esfandiari H, Soheilian M, Ahmadieh H, Dehsarvi B, Yaseri M. Three Intravitreal Bevacizumab Injections vs. 2 Intravitreal Triamcinolone Injections in Recent Onset Retinal Vein Occlusion. *XIX Biennial Meeting of the International Society for Eye Reasearch, Montreal, Canada, 18-23 July 2010. 1. Davari M, Ahmadieh H, Soheili ZS, Sanie Jahromi F, Ghaderi S, Rezaie Kanavi M, Samiei S, Akrami H. Detection of retinal neural cells and progenitors in normal retinal pigment epithelium cultures 2. Sanie Jahromi F, Soheili ZS, Ahmadieh H, Davari M, Ghaderi S, Rezaie Kanavi M, Samiei S, Dizaji A. Detection of retinal progenitor cells in human retinal pigment epithelium (HRPE) cell cultures 3. Ahmadieh H, Ghaderi S, Soheili ZS, Davari M, Sanie jahromi F, Dizaji A, Samiei S, Rezaei Kanavi M, Pakravesh J. Human amniotic fluid promotes retinal pigmented epithelial cells trans-differentiation into rod photoreceptors 4. Ghaderi S, Ahmadieh H, Soheili ZS, Davari M, Sanie Jahromi F, Dizaji A, Samiei S, Rezaei Kanavi M. In vitro transdifferentiation of human retinal pigment epithelial cells into rod photoreceptors & retinal ganglion cells 5. Nourinia R, Ahmadieh H, Soheili ZS, Akrami H, Rezaie Kanavi M. Knockdown of the placental growth factor (PLGF) gene inhibits laser induced choroidal neovascularization in a murine model 6. Davari M, Ahmadieh H, Soheili ZS, Sanie Jahromi F, Ghaderi S, Rezaie Kanavi M, Samiei S, Akrami H, Pakravesh J. Manifestation of retinal neurons and progenitors in retinal pigment epithelium cultures treated by amniotic fluid 7. Sanie Jahromi F, Soheili ZS, Ahmadieh H, Davari M, Ghaderi S, Rezaie Kanavi M, Samiei S, Dizaji A, Pakravesh J. Neural progenitor cells arising from amniotic fluid (AF) treated retinal pigment epithelium (RPE) cell cultures 8. Bagheri A, Soheili ZS, Ahmadieh H, Alipour SD, Samiei S, Rezaei M, Dizaji A.. The effect of bevacizumab on mmp-2 production and activity in human retinal pigment epithelial cell culture * Amerrican Academy of Ophthalmology (AAO), 22-25 October 2011, Orlando, USA. 1. Moradian S, Hamid Ahmadieh, Faghihi Habibabadi H, Ramezani Ar, Entezari M, Banaii T, Heidari E, Behboodi H, Mahmoodi AH, Yaseri M. Comparison of Visual and Anatomical Outcomes of 4 Surgical Techniques in the Management of Pseudophakic and Aphakic Retinal Detachment (POSTERS) *ASRS 29th Annual Meeting, 20-24 August 2011, Boston-USA 1. Ahmadieh H, Banaee T, Behboudi H, Ramezani Ar , Movaseghi M. Combined 5FU, Low molecular weight heparin, dexamethasone and oral colchicine for established PVR; a Randomized Clinical Trial 2. Ahmadieh H, Nourinia R, Soheila Soheili Z, Akrami H. Knockdown of the placental growth factor (PlGF) gene inhibits laser induced choroidal neovascularization in a Murine Model 3. Monshizadeh R, Ahmadieh H. Tariq M. Bhatti. Optic nerve dysfunction and disc edema associated with long term use of anastrozole *11th Euretina Congress, 26-29 May, 2011, London, UK. 1. Samiei S, Bagheri A, Soheili Z, Ahmadieh H, Alipour SD, Rezaei M, Dizaji A. Anti-CTGF Affects MMP-2 Quantity and Activity in Human Retinal Pigment epithelial (RPE) Ceell Culture (POSTER) 2. A Bagheri, Z Soheili, Ahmadieh H, SD Alipour, S Samiei, M Rezaei, A Dizaji. Bevacizumab in Different Concentrations Affects MMP-2 Production and Activity in Human Retinal Pigment Epithelial Cell Culture (POSTER) 3. Ahmadieh H. Bevacizumab is Able to Alter MMP-2, TIMP-1 and TIMP-2 Transcription Levels in RPE Cells 4. Ahmadieh H, Bagheri A, Soheili Z, Alipour SD, Samiei S, Rezaei-Kanavi M, Dizaji A. Bevacizumab Varies Transcription of Cathepsin D and asmooth Muscle Action in Human Retinal Pigment Epithelial (RPE) Cells (POSTER) 5. Soheili S, Ahmadieh H. CTGF Neutralizing Antibody Influences MMP-9 Activity and Quantity in Human retinal Pigment Epithelial (RPE) Cell Culture. 6. Soheili Z, Nazemroaya F, Deezajji A, Ahmadieh H. Human Retinal Pigment Epithelial Cell (RPE) Culture on PolyHEMA Coated Culture Substrates (POSTER) 7. Bagheri A, Soheili Z, Ahmadieh H, Alipour SD, Samiei S. Identification of Ikaros Gene Expression in Human Retinal Pigment Epithelial Cells (POSTER) 8. S Samiei,A Bagheri, Z soheili, H Ahmadieh, SD Alipour, M Rezaei, A Dizaji. The Effect of Bevacizumab on MMP-9 Production and Activity in Human Retinal pigment Epithelial Cell Culture (POSTER) 9. Soheili S, Bagheri A, Ahmadieh H, Alipour SD, Samiei S, Rezaei-Kanavi M, Dizaji A. The Effect of Bevacizumab on VEGF-A, VEGFR Genes Transcription in RPE Cell culture (POSTER) 10. Soheili S, Bagheri A, Ahmadieh H, Alipour SD, Samiei S, Rezaei-Kanavi M, Dizaji A. CTGF Neutralizing Antibody Influences MMP-9 Activity and Quality in Human Retinal Pigment Epithelial (RPE) Cell Culture 11. Ahmadieh H, Bagheri A, Soheili Z, Alipour SD, Samiei S, Rezaei-Kanavi M, Dizaji A. Bevacizumab is Able to Alter MMP-2, TIMP-1 and TIMP-2 Transcription Levels in RPE cells *3rd Asia-ARVO Meeting January 20–22, 2011 Singapore 1. Davari M, Ahmadieh H, Soheili ZS, Sanie-Jahromi F, Ghaderi S, Rezaei_Kanavi M, Samiei S, Pakravesh J. Amniotic Fluid Induces Transition of Retinal Pigment Epithelial Cultures to Neural Fate 2. Katibeh M, Rajavi Z, Ziaei H, Ahmadieh H, Javadi MA. Cataract Surgery Barriers: A Population-Based Study in Iran 3. Sanie-Jahromi F, Soheili ZS, Ahmadieh H, Davari M, Ghaderi S, Rezaie Kanavi M, Samiei S, Dizaji A, Pakravesh J. Amniotic Fluid (AF) Promotes Retinal Progenitor Cell Establishment in Retinal Pigmented Epithelium (RPE) Cell Cultures 4. Ahmadieh H, Banaee T, Behboudi H, Ramezani A, Movaseghi M, Rostami P, Yaseri M. Combined 5-Flourouracil, Low Molecular Weight Heparin, Dexamethasone and Oral Colchicine for Established Proliferative Vitreoretinopathy: A Clinical Trial 5. Zahabi A, Shahbazi E, Daftarian N, Satarian L, Kiani S, Ahmadieh H, Mehrnejad F, Baharvand H. Differentiation of Retinal Pigmented Epithelial Cells from Human Induced Pluripotent Stem Cells and Transplantation in Retinal Degeneration Rat Model 6. Ghaderi S, Ahmadieh H, Soheili ZS, Davari M, Sanie Jahromi F, Samiei S, Rezaei Kanavi M, Pakravesh J, Dizagi A. Dose Dependant Trophic Effect of Human Amniotic Fluid on the Retinal Pigment Epithelial Cells Transdifferentiation into the Retinal Ganglion Cells 7. Ahmadieh H, Nourinia R, Soheili ZS, Rezaei-Kanavi M, Samiei S, Akrami H. Knockdown of the Placental Growth Factor (PlGF) Gene Inhibits Laser-Induced Choroidal Neovascularization in a Murine Model 8. Ahmadieh H, Bagheri A, Soheili ZS, Darvishalipourastaneh S, Samiei S, RezaeiKanavi M, Dizaji A. Significant Increase in Alpha Smooth Muscle Actin Positive Cells in Higher Passage Numbers of Retinal Pigment Epithelial Cell Cultures *XX Biennial Meetng of the International Society for Eye Research (ISER 2012), 2125 July, 2012, Berlin-Germany. 1. Katibeh M, Ziaei H, Rajavi Z, Hosseini S, Javadi MA, Ahmadieh H. A Profile of Cataract Surgery in Iran: A Population Based Study On Adults 2. Ahmadieh H, Bagheri A, Soheili ZS, Samiei S, Alipour SD, Rezaei Kanavi M. The Effects of Bevacizumab Combined With Anti-CTGF Neutralizing Antibody on MMP-2 and Gene Expression of VEGF-A, VEGFR-1 And Cathepsin D In Human RPE Cultures 3. Nazemroaya F, Soheili ZS, Deezagi A, Heidari R, Ahmadieh H, Samiei S. Trans-differentiation of Human Retinal Pigmented Epithelium on Polyhema as a Cell Culture Substrate 4. F Nazemroaya, ZS Soheili, A Deezagi, R Heidari, H Ahmadieh, S Samiei. Effect of Polyhema as a Cell Culture Substrate on De-differentiation of Human Retinal Pigmented Epithelium *Amerrican Academy of Ophthalmology (AAO), 10-13 November 2012, Chicago, USA. 1. Ahmadieh H, Pakravan M, Hafezi –Moghadam A, Norinia R, Sanjari N, Zandi S, Nakao S, Shah-Heidari MH, Yaseri M. Intravitreal injection of a Rho-Kinase inhibitor (Fasudil) for recent onset non-arteritic anterior ischemic optic neuropathy *WOC2014, April 2–6, Tokyo. 1. Hamid Ahmadieh.Emerging Fundus Imaging Techniques. 2. Homayoon Nikkhah, Hamid Ahmadieh, Ramin Nourinia, Mozhgan Rezaei Kanavi, Naficeh Sadeghi.Safety of Intravitreal Imatinib and Its Efficacy in Inhibition of Experimental Choroidal Neovascularization . 3. Mohammadali Gholipour, Hamid Ahmadieh, Seyed Javid Aldavood, Ramin Nourinia, Mozhgan Rezaei Kanavi, Saeid Amanpour, Bagher Hosseini, Ebrahim Mohammad Nashtaei , Adib Toosi .Intravitreal Topotecan Inhibits Laser Induced Choroidal Neovascularization in a Rat Model. 4. Hamid Ahmadieh, Mohammad Pakravan, Ramin Nourinia, Nasrin Sanjari. Intravitreal Fasudil Injection for Treatment of Recent Onset NonArteritic Anterior Ischemic Optic Neuropathy. 5. Hamid Ahmadieh, Ramin Nourinia, Ali Hafezi-Moghadam.ROCK as a New Target for Treatment of Diabetic Macular Edema: A Pilot Study. 6. Hamid Ahmadieh, Ramin Nourinia, Kiana Kamrava, Saeed Karimi.Determination of the Safe Dose of Intravitrealzoledronic Acid (An Anti-Angiogenic Bisphosphonate) in an Experimental Study. 7. Anoushiravan Rahimi Gharah Mirshamloo,Hamid Ahmadieh, Sare Safi, Afsaneh Raeesi, Eduardo Solessio.Scotopic Contrast Sensitivity in Diabetic Patients with No Diabetic Retinopathy. 8.Ramezani A , Rozegar A, Ahmadieh H , Soheilian M , Entezari M.Outcomes of Diabetic Vitrectomy with Silicone Oil Injection. *ARVO 2014 Annual Meeting – Orlando, Fla, May 4 – 8 1. Sahar Balagholi; Narges Fazili; Abouzar Bagheri; Somayeh Asadi; Mozhgan Rezaei Kanavi; Hamid Ahmadieh; Zahra-Soheila Soheili; Shahram Samiei .Morphologic Changes of Cultivated Uveal Melanoma Cells with Increasing of Passages. 2.Sare Safi; Hamid Ahmadieh; Anoushiravan Rahimi; Eduardo C. Solessio; Afsaneh Raeesi; Hamid Safi; Mohammad Haeri; Mohammad Aghazadeh Amiri; Mojtaba Malek; Mehdi Yaseri. Scotopic Contrast Sensitivity in Diabetic Patients with No Diabetic Retinopathy 3.Mozhgan Rezaei Kanavi; Hamid Ahmadieh; Ramin Nourinia; Amirreza Kahrkaboudi; Adib Tousi; Bagher Hosseini; Seyed Iman Taghavi Dinani; Seyed Javid Aldavood . Ocular Safety of Intravitreal Propranolol in a Rabbit Model 4.Hamid Ahmadieh; Mohammad Ali Gholipour; Seyed Javad Aldavood; Ramin Nourinia; Mozhgan Rezaei Kanavi. Intravitreal Topotecan Inhibits Laser Induced Choroidal Neovascularization in a Rat Model *ARVO 2015 Annual Meeting – Denver, Colorado, May 3-7 1. Hamid Ahmadieh, Somayeh Asadi, Sahar Balagholi, Mozhgan Rezaeikanavi, Mostafa Olfat, Narges Fazili, Mehdi Vaez-Zadeh. The Effects of Gold Nanoparticles on the Choroidal Melanoma Cells: An In VitroStudy Local Congresses 1991 President of the First Iranian Congress of Ophthalmology 1992 2nd Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 1993 3rd Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 1994 4th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 1995 President of the First International Congress of Ophthalmology of Iran Head of the Executive Committee of the 5th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 1996 6th Iranian Congress of Ophthalmology Lecturer 1997 7th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 1998 8th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 1999 9th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2000 10th Iranian Congress of Ophthalmology Lecturer, Member of Scientific Committee 2001 11th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2002 12th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2003 13th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2004 14th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2005 15th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2006 16th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2007 17th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2008 18th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2009 19th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2010 20th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2011 21st Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2012 22nd Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2013 23nd Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee 2014 24th Iranian Congress of Ophthalmology Lecturer, Member of the Scientific Committee